Pharma News

Daily magnesium intake may be beneficial in preventing pancreatic cancer, researchers from Indiana University (IU) have found.

Vices such as AIDS and drug addiction are against the Indian tradition and should be tackled effectively, Goa Governor Mridula Sinha said in her address on the eve of the state's Liberation Day.

With nearly 5.2 million medical injuries recorded each year in India, an Assam professor, who recently lost his wife due to "utter callousness" of doctors has begun spreading awareness about medical negligence which he claims has acquired "endemic proportions" in the country.

In a rare surgery, a 26-year-old youth saved his father's life by donating a portion of his liver in spite of having a different blood group, hospital officials said on Saturday.

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Methylprednisolone Sodium Succinate Injection USP, 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial.

The U.S. Food and Drug Administration approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Basaglar is manufactured by Eli Lilly and Company in Indianapolis, Indiana.

The U.S. Food and Drug Administration  approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Bridion is marketed by Merck Sharp and Dohme Corp., a subsidiary of Merck and Company, Inc., based in Whitehouse Station, New Jersey.

U.S. Department of Justice entered a consent decree of permanent injunction in the District of Vermont against the Correia Family Limited Partnership, doing business as Wynsum Holsteins, a dairy farm located in West Addison, Vermont, and its partners, Anthony Correia, Barbara Correia and Stephen Correia. The decree accompanies a complaint filed at the request of the U.S. Food and Drug Administration.

AstraZeneca  announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”). The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the US and Daxas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Loperamide Hydrochloride Tablet, 2 mg. This product is expected to be launched in Q4 FY2015-16.